ArticleJournal of ovarian research2016

Strong synergy with APR-246 and DNA-damaging drugs in primary cancer cells from patients with TP53 mutant High-Grade Serous ovarian cancer.

Åsa Fransson et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.